February 11th 2025
Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, biomarkers, and other cancer treatments, will be highlighted at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU).
February 7th 2025
Watch the series now!
PCOC SPOTLIGHT: Empowering Stakeholders Across the Breadth of Oncology
US Oncology Network, Tennessee Oncology Tout Medicare OCM Savings
Dr Funmi Olopade: Breast Cancer Screening Is Not One Size Fits All
Spotlighting Social, Emotional Needs in Underserved Populations With Cancer